Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FF1L1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,376
Award facts
- Contract value 100% obligated
- $10,376.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,376.02 to AmerisourceBergen Drug Corp for the supply of DUPIXENT (dupilumab) 300 mg/2 mL pen injectors on January 22, 2026, with a completion date of January 23, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical products will be delivered to the contractor's location in Conshohocken, Pennsylvania. DUPIXENT is a biologic medication used to treat conditions including moderate-to-severe eczema, asthma, and chronic rhinosinusitis with nasal polyps, and this delivery order represents a routine replenishment of pharmaceutical inventory for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This primary IDC vehicle enables Cencora and its subsidiary AmerisourceBergen to serve as a pharmaceutical prime vendor supplying a comprehensive range of medications, vaccines, medical devices, and healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. The contract demonstrates the critical role pharmaceutical distributors play in maintaining the medical supply chain for the Department of Defense and related federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FF1L1?
SPE2DR26FF1L1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FF1L1 worth?
The government has obligated $10,376 on SPE2DR26FF1L1.
Is contract SPE2DR26FF1L1 an order under another contract?
Yes. SPE2DR26FF1L1 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FF1L1 competed?
The extent of competition for SPE2DR26FF1L1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award